This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2022
Title: Tasha Nicholle Sims: Innovator in Cancer Therapy
Introduction
Tasha Nicholle Sims is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of cancer therapy, particularly in the treatment of metastatic colorectal cancer. With a total of 2 patents, her work focuses on innovative methods that enhance patient outcomes.
Latest Patents
Her latest patents include groundbreaking inventions related to anti-angiogenic therapy for metastatic colorectal cancer. The first patent provides methods for treating metastatic cancer by identifying subjects who will respond favorably to anti-VEGF therapy. This identification is based on the expression levels of predictive biomarkers, with high or low levels indicating a favorable response. An exemplary predictive biomarker mentioned is VEGF-A. Additionally, the patent discloses prognostic biomarkers that help identify cancer-bearing subjects expected to have better relative survival outcomes.
The second patent mirrors the first, emphasizing the importance of predictive and prognostic biomarkers in the treatment of metastatic colorectal cancer. This innovative approach aims to improve the efficacy of anti-VEGF therapy by tailoring treatment to individual patient profiles.
Career Highlights
Tasha Sims is currently associated with Regeneron Pharmaceuticals, Inc., where she continues to advance her research in cancer therapies. Her work has garnered attention for its potential to revolutionize treatment protocols and improve survival rates for patients with metastatic cancer.
Collaborations
Throughout her career, Tasha has collaborated with notable colleagues, including Bo Gao and Israel Lowy. These partnerships have fostered a collaborative environment that enhances the development of innovative cancer therapies.
Conclusion
Tasha Nicholle Sims is a trailblazer in the field of cancer therapy, with her patents paving the way for more effective treatments. Her dedication to research and innovation continues to impact the lives of many patients battling metastatic colorectal cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile